Bleakley Financial Group LLC Takes $671,000 Position in Haleon PLC Sponsored ADR $HLN

Bleakley Financial Group LLC acquired a new stake in Haleon PLC Sponsored ADR (NYSE:HLN) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 64,712 shares of the company’s stock, valued at approximately $671,000.

Several other institutional investors have also added to or reduced their stakes in HLN. Brighton Jones LLC purchased a new stake in Haleon during the 4th quarter valued at $187,000. Wealth Enhancement Advisory Services LLC boosted its position in Haleon by 18.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 94,748 shares of the company’s stock valued at $975,000 after buying an additional 14,935 shares during the period. Oppenheimer & Co. Inc. boosted its position in Haleon by 11.2% during the 1st quarter. Oppenheimer & Co. Inc. now owns 25,362 shares of the company’s stock valued at $261,000 after buying an additional 2,564 shares during the period. PDS Planning Inc boosted its position in Haleon by 8.0% during the 1st quarter. PDS Planning Inc now owns 21,645 shares of the company’s stock valued at $223,000 after buying an additional 1,598 shares during the period. Finally, Bartlett & CO. Wealth Management LLC boosted its position in Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after buying an additional 1,491 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Trading Down 1.3%

NYSE:HLN opened at $9.25 on Monday. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $9.38 and a 200-day moving average price of $9.98. The stock has a market cap of $41.17 billion, a price-to-earnings ratio of 23.71, a P/E/G ratio of 2.70 and a beta of 0.20. Haleon PLC Sponsored ADR has a 12 month low of $8.71 and a 12 month high of $11.42.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were paid a $0.0555 dividend. This represents a dividend yield of 190.0%. The ex-dividend date was Friday, August 15th. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. Haleon’s dividend payout ratio (DPR) is 28.21%.

Analysts Set New Price Targets

Several brokerages have weighed in on HLN. The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research report on Saturday. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. Finally, Wall Street Zen cut shares of Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.